Clinical trials and translational medicine
4 European H2020 organizations list this as part of their work — 4 as their primary capability.
Most active in this area
- EBERHARD KARLS UNIVERSITAET TUEBINGEN
Leading German research university in neuroscience, RNA therapeutics, and clinical trials, with strong ERC track record and translational medicine platforms.
“Runs multi-centre trials including FAIR-PARK-II (Parkinson's iron chelation), ALBINO (neonatal neuroprotection), REGAIN (hearing regeneration), and Ebola vaccine studies (VSV-EBOVAC, VSV-EBOPLUS).”
PrimaryDE145 projects - KLINIKUM DER UNIVERSITAET ZU KOELN
German university hospital combining neuroscience, cancer biology, and clinical trials with growing strength in health economics and cost-effectiveness evaluation.
“Involved in multiple clinical trial projects including BETA3_LVH, OligoGpivotalCF (cystic fibrosis), FURTHER (focused ultrasound), BETTER-B (palliative breathlessness), and NISCI (spinal cord injury).”
PrimaryDE41 projects - HOSPICES CIVILS DE LYON
Major French university hospital contributing clinical trials, patient cohorts, and biobanks to European health research across infectious disease, oncology, and neurology.
“Central to projects like TENSION (stroke thrombectomy trial), ImmunoSep (personalized sepsis therapy), HAP2 (hospital-acquired pneumonia), and IP-cure-B (hepatitis B clinical trial).”
PrimaryFR16 projects - CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE
French university hospital contributing clinical neuroscience expertise to the Human Brain Project and running stem cell and transplant clinical trials.
“Ran or contributed to phase II/III trials across stroke recovery (RESSTORE), osteoarthritis (ADIPOA2), kidney transplant immunosuppression (TTV GUIDE TX), and cell therapy.”
PrimaryFR12 projects